“…(CmHmFNOj) C, H, N. l-Amino-2-(2'-fluorobenzoyl)naphthalene (32). 1 -(IV-Benzoylamino)-2-(2'-fluorobenzoyl)naphthalene (31) (3.05 g, 8.3 mmol) was treated according to procedure d to afford 32 (2.2g, 95%) as light green-yellow crystals: mp 119-121 °C; IR (KBr) 3499, 3377 (NH2), 3058,1612 (C=0), 1520,1483, 913, 815, 741 cm-1; >H NMR (CDCls) S 6.94 (d, 1H, J = 8.3 Hz), 7.11-7.30 (m, 3H), 7.41-7.51 (m, 3H), 7.57 (dt, 1H, J = 1.2, 8.1 Hz), 7.70 (br s, 2H, NH2), 7.71 (dd, 1 H, J = 1.2,8.3 Hz), 7.96 (34) (1.3 g, 5 mmol) was treated as described in procedure c with 2 equiv of (o-fluorophenyl)lithium, and this was followed by treatment analogous to procedure d to afford 36 (0.93 g, 71 %) as light brown crystals (hexane/EtOAc): mp 98-99 °C; XH NMR (CDCls) & 5.60 (br s, 2H, NH2), 6.90 (d, 1H, J = 9 Hz), 6.98-7.17 (m, 4H), 7.17-7.40 (m, 2H), 7.26 (d, 1H, J =9 Hz), 7.62 General Procedure e To Prepare Bromoacetyl Amides. l-[/V-(Bromoacetyl)amino]-2-benzoylnaphthalene (16).…”